Fabry expert en Suisse centrale

Prof. Dr. med. Uyen Huynh-Do, MME

Department of Nephrology & Hypertension
University of Bern, Inselspital
3010 Bern
Tel: +41 (0)31 632 3141/3144
Email: uyen.huynh-do@insel.ch


2016 Certificate of Advanced Studies (CAS) in Entrepreneurship, Faculty of
Business, Economics and Social Sciences, University of Bern, Switzerland
2011 Certificate in Business Excellency, Columbia Business School, Columbia University USA
2009 Master of Medical Education (MME UniBE), University of Bern & Department
of Medical Education, University of Illinois at Chicago, Chicago, IL, USA
2008 Associate Professor, Faculty of Medicine, University of Bern, Switzerland
2004 Habilitation (venia docendi), Faculty of Medicine, University of Bern, Switzerland
1987 Doctor in Medicine (MD), University of Zürich Medical School, Switzerland
1985 Swiss Federal Diploma of Physician


Current Position Associate Professor, Department of Nephrology & Hypertension
University of Bern Medical School, Inselspital, CH-3010 Bern, Switzerland
2009 Guest Professor, Dept. of Medical Education, University of Illinois, Chicago, IL, USA
2008- Associate Professor, Div. of Nephrology and Hypertension, University of Bern Medical School, Inselspital, Bern, Switzerland
1999-2004 Attending Physician, Department of Nephrology and Hypertension, Inselspital Bern
1996-1999 Postdoctoral Research Fellow, Division of Nephrology, Vanderbilt Center for Vascular Biology, Vanderbilt University Medical Center, Nashville, TN, USA
1995 Senior Medical Officer, Medical Clinic and Division of Nephrology, Waid Hospital, Zürich, Switzerland
1993-1994 Clinical fellow, Division of Nephrology, Department of Internal Medicine, University Hospital Zürich, Zürich, Switzerland
1989-1991 Resident, Medical Clinic, University Hospital Bern Inselspital, Bern, Switzerland
1987-1989 Resident, Medical Clinic, University Hospital, Zürich, Switzerland

Adhésions et participation aux conseils et aux panels

  • Swiss Society of Nephrology (SSN): President (2018-2019)
  • Swiss Transplantation Society (STS); Swiss Transplantation Cohort Study (STCS): co-applicant and scientific committee
  • Swiss Systemic lupus Erythematodes Cohort Study (SSCS): steering committee
  • Swiss Academy of Medical Sciences: delegate of the University of Bern
  • EUPATI: European Patient Academy, Swiss branch
  • European Dialysis and Transplantation Association (EDTA)
  • American Society of Nephrology (ASN), International Society of Nephrology (ISN)

Grants, Awards

2014-2018 EU Grant (FP7-PEOPLE-COFUND-2013) for the Postdoctoral Program in Integrative Kidney Physiology & Pathophysiology2 (IKPP2 -Grant 608847)
2013-2015 Grant of the Commission for Technology and Innnovation (CTI) Nr. 15622.1 of the Swiss Confederation
2010-2013 EU Grant (FP7-PEOPLE-COFUND-2008) for the Postdoctoral Program in Integrative Kidney Physiology & Pathophysiology (IKPP-Grant 246539)
2010- NCCR (National Center of Competence in Research)Kidney. CH grant of the Swiss National Science Foundation
2007-2010 Research Grant 3100-11’8369 of the Swiss National Science Foundation
2006 Research Grant of the Novartis Foundation for MedicalBiological Research
2004-2007 Research Grant 3100-10’5871 of the Swiss National Science Foundation
2001-2004 Research Career Development Grant “Score B”of the Swiss National Science Foundation
2000-2003 Research Grant 31-59’419.99 of the Swiss National Science Foundation
1999 First Poster Award of the Vanderbilt Cancer Center,Vanderbilt University, Nashville, TN, USA
1997-1999 Grant of the Swiss Foundation for Medical & Biological Research
1996-1997 Research Grant 31-59’419.99 of the Swiss National Science Foundation
1988 First Prizeof the Swiss Society of Internal Medicine


  • German
  • English


Peer-reviewed publications in clinical medicine

  1. Tedesco-Silva H, Pascual J, Viklicky O, Basic-Jukic N, Cassuto E, Kim DY, Cruzado JM, Sommerer C, Adel Bakr M, Garcia VD, Huynh-Do U, Russ G, Kim MS, Kuypers D, Buchler M, Citterio F, Hernandez Gutierrez MP, Bernhardt P, Chadban S, on behalf of the TRANSFORM Investigators. Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized TRANSFORM study.
    Transplantation 2019 [IF: 3.9, R: 7/25]
  2. Nehring J, Schirmbeck LA, Friebus-Kardash J, Dubler D, Huynh-Do U, Chizzolini C, Ribi C, Trendelenburg M. Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.
    Front Immunol. 2018 Oct 2; 9:2090. doi: 10.3389/fimmu.2018.02090. [IF: 5.5: R: 3/166]
  3. Pröbstel AK, Thanei M, Erni B, Lecourt AC, Branco L, André R, Roux-Lombard P, Koenig KF, Huynh-Do U, Ribi C, Chizzolini C, Kappos L, Trendelenburg M, Derfuss T. Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus.
    Rheumatology (Oxford) 2018 Sep 27. doi: 10.1093/rheumatology/key282. [IF: 5.2: R: 5/31]
  4. Kummer M, Šestáková N, Theurillat R, Huynh-Do U, Endimiani A, Sendi P, Thormann W. Monitoring of cefepime in urine by micellar electrokinetic capillary chromatography with ultraviolet detection and liquid chromatography coupled to mass spectrometry.
    J Sep Sci. 2018 Nov;41(21):4067-4074. doi: 10.1002/jssc.201800763. [IF: 2.4, R: 33/81]
  5. Neofytos D, Hirzel C, Boely E, Lecompte T, Khanna N, Mueller NJ, Boggian K, Cusini A, Manuel O, van Delden C; Swiss Transplant Cohort Study. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Transpl Infect Dis. 2018 Aug 28: e12984. doi: 10.1111/tid.12984. [IF: 1.9, R: 15/25]
  6. Kuster S, Stampf S, Gerber B, Baettig V, Weisser M, Gerull S, Medinger M, Passweg J, Schanz U, Garzoni C, Berger C, Chalandon Y, Mueller NJ, van Delden C, Neofytos D, Khanna N; Swiss Transplant Cohort Study. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
    Transpl Infect Dis. 2018 Aug 25: e12981. doi: 10.1111/tid.12981. [IF: 1.9, R: 15/25]
  7. Schreiber PW, Bischoff-Ferrari HA, Boggian K, van Delden C, Enriquez N, Fehr T, Garzoni C, Hirsch HH, Hirzel C, Manuel O, Meylan P, Saleh L, Weisser M, Mueller NJ; Swiss Transplant Cohort Study (STCS). Vitamin D status and risk of infections after liver transplantation in the Swiss Transplant Cohort Study.
    Transpl Int. 2018 Aug 12. doi: 10.1111/tri.13328. [IF: 3.2, R: 10/25]
  8. Walder A, Müller M, Dahdal S, Sidler D, Devetzis V, Leichtle AB, Fiedler MG, Popp AW, Lippuner K, Vogt B, Uehlinger D, Huynh-Do U, Arampatzis S. The effect of a previous created distal arteriovenous-fistula on radial bone DXA measurements in prevalent renal transplant recipients.
    PLoS One. 2018; 13(7): e0200708. doi: 10.1371/journal.pone.0200708. [IF: 2.8; R: 8/56]
  9. Beckmann S, Denhaerynck K, Stampf S, Saigi-Morgui N, Binet I, Koller M, Boely E, De Geest S; Psychosocial Interest Group; Swiss Transplant Cohort Study. New-onset obesity after liver transplantation-outcomes and risk factors: the Swiss Transplant Cohort Study.
    Transpl Int. 2018 Jun 21. doi: 10.1111/tri.13308. [IF: 3.2, R: 10/25]
  10. Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation
    J Am Soc Nephrol. 2018; 29:1979-1991. [IF: 8.96, R: 3/77]
  11. Ersözlü S, Desnick RJ, Huynh-Do U, Canaan-Kühl S, Barbey F, Genitsch V, Müller T, Cheetham M, Flammer A, Schaub S, Nowak A. Long-Term Outcomes of Kidney Transplantation in Fabry Disease.
    Transplantation. 2018 Apr 24. doi: 10.1097/TP.0000000000002252. [IF: 3.9, R: 7/25]
  12. Marchetti T, Ribi C, Perneger T, Trendelenburg M, Huynh-Do U, de Moerloose P, Chizzolini C.
    Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus.
    Rheumatology (Oxford). 2018 Apr 17. doi: 10.1093/rheumatology/key095. [IF: 5.2: R: 5/31]
  13. Neofytos D, Chatzis O, Nasioudis D, Boely Janke E, Doco Lecompte T, Garzoni C, Berger C, Cussini A, Boggian K, Khanna N, Manuel O, Mueller NJ, van Delden C; Swiss Transplant Cohort Study. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
    Transpl Infect Dis. 2018 Apr 18: e12898. doi: 10.1111/tid.12898. [IF: 1.9, R: 15/25]
  14. Coussement J, Maggiore U, Manuel O, Scemla A, López-Medrano F, Nagler EV, Aguado JM, Abramowicz D; European Renal Association-European Dialysis Transplant Association (ERA-EDTA) Developing Education Science and Care for Renal Transplantation in European States (DESCARTES) working group and the European Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe.
    Nephrol Dial Transplant. 2018 Apr 9. doi: 10.1093/ndt/gfy078. [IF: 4.4; R: 10/77]
  15. Dahdal S, Devetzis V, Chalikias G, Chizzolini C, Ribi C, Trendelenburg M, Pasch P, Huynh-Do U, Arampatzis S*, for the Swiss Systemic Lupus Erythematosus Cohort Study Group (SSCS). Serum Calcification Propensity is independently associated with disease activity in Systemic Lupus Erythematosus.* both authors contributed equally to the manuscript
    Plos One 2018; 13(1):e0188695. [IF: 2.8; R: 8/56]
  16. Cusini A, Béguelin C, Stampf S, Boggian K, Garzoni C, Koller M, Manuel O, Meylan P, Mueller NJ, Hirsch HH, Weisser M, Berger C, van Delden C. and Swiss Transplant Cohort Study (2018). Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.
    Am J Transplant 2018. doi: 10.1111/ajt.14640. [IF: 5.7, R: 2/25]
  17. Burkhalter H, Denhaerynck K, Huynh-Do U, Binet I, Hadaya K, De Geest S, for the Psychosocial Interest Group, Swiss Transplant Cohort Study. Prevalence and Change of Sleep Quality from Pre- to 3 years Post-Solid Organ Transplantation: The Swiss Transplant Cohort Study
    Plos One 2017; 12(10):e0185036. [IF: 2.8; R: 8/56]
  18. Friebus-Kardash J, Branco L, Ribi C, Chizzolini C, Huynh-Do U, Dubler D, Dolff S, Kribben A, Eisenberger U, Trendelenburg M. Immune complexes containing serum B-cell activating factor and immunoglobulin G correlate with disease activity in systemic lupus erythematosus.
    Nephrol Dial Transpl. 2018; 33(1):54-64 [IF: 4.4; R: 10/77]
  19. Siegenthaler M, Huynh-Do U, Krayenbuehl P, Pollock E, Widmer U, Debaix H, Olinger E, Frank M, Namdar M, Ruschitzka F, Nowak A. Impact of Cardio-Renal Syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up.
    Int J Cardiol. 2017; 249:261-267. [IF: 6.2; R: 16/126
  20. Burkhalter F, Huynh-Do U, Hadaya K, Matter M, Mueller T, Binet I, Nolte B, Steiger J. Early and late complications after living donor nephrectomy: a prospective analysis of the Swiss Organ-Living Donor Health Registry. Swiss Med Weekly 2017 [IF: 1.7]
  21. Arampatzis S, Chalikais G, Devetzis V, Konstantiides S, Huynh-Do U and Tziakas D. C-terminal fragment of agrin (CAF) levels predict acute kidney injury after acute myocardial infarction.
    BMC Nephrology 2017; doi: 10.1186/s12882-017-0611-9 [IF: 2.3; R: 31/77]
  22. Chaigne B, Chizzolini C, Perneger T, Trendelenburg M, Huynh-Do U, Dayer E, Stoll T, Von Kempis J, Ribi C. Impact of disease activity on health-related quality of life in systemic lupus erythematosus – a cross-sectional analysis of the Swiss Systemic Lupus Erythematosus Cohort Study (SSCS).
    BMC Immunology 2017; 18(1):17 [IF: 2.2]
  23. Céline Leboeuf C, Wilk S, Achermann R, Binet I, Bochud PY, van Delden C, Goldhayan D, Hadaya K, Hirzel C, Huynh-Do U, Koller M, Manuel O, Mueller NJ, Müller T, Schaub S, Weissbach S, Hirsch HH. BK polyomavirus-specific 9mer T-cell responses predict control of viremia in kidney transplant recipients: First report from the Swiss Transplant Cohort Study (STCS)
    Am J Transplant. 2017; 17:2591-2600. [IF: 5.7, R: 2/25]
  24. Beaume M, Köhler T, Greub G, Manuel O, Aubert JD, Baerlocher L, Farinelli L, Buckling A, van Delden C; Swiss Transplant Cohort Study. Rapid adaptation drives invasion of airway donor microbiota by Pseudomonas after lung transplantation.
    Sci Rep. 2017 Jan 17; 7: 40309. doi: 10.1038/srep40309. [IF: 5.2, R: 7/63]
  25. Martin-Gandul C, Stampf S, Héquet D, Mueller NJ, Cusini A, van Delden C, Khanna N, Boggian K, Hirzel C, Soccal P, Hirsch HH, Pascual M, Meylan P, Manuel O; Swiss Transplant Cohort Study (STCS). Preventive Strategies against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.
    Am J Transplant. 2016 Dec 31. doi: 10.1111/ajt.14192. [IF: 5.7, R: 2/25]
  26. Beckmann S, Nikolic N, Denhaerynck K, Binet I, Koller M, Boely E, De Geest S; Psychosocial Interest Group, Swiss Transplant Cohort Study. Evolution of body weight parameters up to 3 years after solid organ transplantation: The prospective Swiss Transplant Cohort Study.
    Clin Transplant. 2016 Dec 23. doi: 10.1111/ctr.12896. [IF: 1.8, R: 16/25]
  27. Nowak A, Koch G, Huynh-Do U, Siegenthaler M, Marti HP, Pfister M. Disease progression modeling to evaluate the effects of enzyme replacement therapy on kidney function in adult patients with the Classic phenotype of Fabry disease.
    Kidney Blood Press Res. 2017; 42:1-15. [IF 2.9, R: 20/77]
  28. Mauthner O, Veerle C, Walston J, Engberg S, Binet FI, Dickenmann M, Golshayan D, Hadaya K, Huynh-Do U, Calciolari S, De Geest S. ExplorinG frailty and mild cognitive impairmEnt in kidney tRansplantation to predict biomedicAl, psychosocial, and health costs outcomeS (GERAS): protocol of a nationwide prospective cohort study. For the GERAS study consortium, and the Psychosocial Interest Group, Swiss Transplant Cohort Study (STCS)
    J Adv Nurs 2016 Oct 12. doi: 10.1111/jan.13179 [IF: 1.9, R: 8/114]
  29. Ebner L, Walti LN, Rauch A, Furrer H, Cusini A, Meyer AMJ, Weiler S, Huynh-Do U, Heverhagen J, Arampatzis S Christe A. Clinical course, radiological manifestations, and outcome of Pneumocystis pneumonia in HIV patients and renal transplant recipients.
    Plos One 2016; doi 10.1371 [IF: 3.3, R: 8/56]
  30. Héquet D, Kralidis G, Carrel T, Cusini A, Garzoni C, Hullin R, Meylan PR, Mohacsi P, Mueller NJ, Ruschitzka F, Tozzi P, van Delden C, Weisser M, Wilhelm MJ, Pascual M, Manuel O; Swiss Transplant Cohort Study (STCS). Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections
    BMC Infect Dis. 2016 Jul 8; 16:321. doi: 10.1186/s12879-016-1658-0. [IF: 2.6; R: 38/76]
  31. Calmy A, van Delden C, Giostra E, Junet C, Rubbia Brandt L, Yerly S, Chave JP, Samer C, Elkrief L, Vionnet J, Berney T; Swiss HIV and Swiss Transplant Cohort Studies. HIV-Positive-to-HIV-Positive Liver Transplantation.
    Am J Transplant. 2016 Aug; 16(8):2473-8. [IF: 5.7, R: 2/25]
  32. Golshayan D, Wójtowicz A, Bibert S, Pyndiah N, Manuel O, Binet I, Buhler LH, Huynh-Do U, Mueller T, Steiger J, Pascual M, Meylan P, Bochud PY and the Swiss Transplant Cohort Study. Role of Polymorphisms in the lectin pathway of complement activation on the incidence of acute rejection and graft outcome after kidney transplantation.
    Kidney Int. 2016; 89: 927-38 [IF: 8.6, R: 2/78]
  33. Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sørensen SS, Hadaya K, Oberbauer R, Dudley C, De Fijter JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Pérez-Sáez MJ, Mühlfeld A, Orlando G, Clemente K, Lai Q, Pisani F, Kandus A, Baas M, Bemelman F, Ponikvar JB, Mazouz H, Stratta P, Subra JF, Villemain F, Hoitsma A, Braun L, Cantarell MC, Colak H, Courtney A, Frasca GM, Howse M, Naesens M, Reischig T, Serón D, Seyahi N, Tugmen C, Alonso Hernandez A, Beňa L, Biancone L, Cuna V, Díaz-Corte C, Dufay A, Gaasbeek A, Garnier A, Gatault P, Gentil Govantes MA, Glowacki F, Gross O, Hurault de Ligny B, Huynh-Do U, Janbon B, Jiménez Del Cerro LA, Keller F, La Manna G, Lauzurica R, Le Monies De Sagazan H, Thaiss F, Legendre C, Martin S, Moal MC, Noël C, Pillebout E, Piredda GB, Puga AR, Sulowicz W, Tuglular S, Prokopova M, Chesneau M, Le Moine A, Guérif P, Soulillou JP, Abramowicz M, Giral M, Racapé J, Maggiore U, Brouard S, Abramowicz D. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients.
    Neph Dial Transpl. 2016. pii: gfv437 [IF: 3.6; R: 12/78]
  34. Quteineh L, Bochud PY, Golshayan D, Crettol S, Venetz JP, Manuel O, Kutalik Z, Treyer A, Lehmann R, Mueller NJ, Binet I, van Delden C, Steiger J, Mohacsi P, Dufour JF, Soccal PM, Pascual M, Eap CB; and The Swiss Transplant Cohort Study. CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
    Pharmacogenomics J. 2015. doi: 10.1038/tpj.2015.82. [IF: 4.3, R: 37/255]
  35. Devetzis V, Daryadel A, Roumeliotis S, Theodoridis M, Wagner CA, Hettwer S, Huynh-Do U, Ploumis P, Arampatzis S. C-terminal fragment of agrin (CAF): a novel marker for progression of kidney disease in type 2 Diabetics.
    Plos One 2015, DOI: 10.1371/journal.pone.0143524 [IF:3.3, R: 8/56]
  36. Simonetti BG, Mono ML, Huynh-Do U, Michel P, Odier C, Sztajzel R, Lyrer P, Engelter ST, Bonati L, Gensicke H, Traenka C, Tettenborn B, Weder B, Fischer U, Galimanis A, Jung S, Luedi R, De Marchis GM, Weck A, Cereda CW, Baumgartner R, Bassetti CL, Mattle HP, Nedeltchev K, Arnold M. Ischemic stroke in young adults: The Swiss Young Stroke Study (SYSS) J
    Neurology 2015; 262: 2025-32 [IF: 3.4, R: 52/192]
  37. Schmied L, Terszowski G, Gonzalez A, Schmitter K, Hirsch HH, Garzoni C, van Delden C, Boggian K, Mueller NJ, Berger C, Villard J, Manuel O, Meylan P, Hess C, Stern M and the Swiss Transplant Cohort Study. Protection from Varicella Zoster in Solid Organ Transplant recipients carrying killer cell immunoglobulin like receptor B haplotypes.
    Transplantation. 2015; 99:2651-5. [IF: 3.8, R: 4/25]
  38. Wójtowicz A, Lecompte TD, Bibert S, Manuel O, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch H, Khanna N, Mueller NJ, Meylan PR, Pascual M, van Delden C, Bochud PY; Swiss Transplant Cohort Study. PTX3 Polymorphisms and Invasive Mold Infections after Solid Organ Transplant.
    Clin Infect Dis. 2015; 61: 619-22 [IF: 9.4, R: 2/78]
  39. Wójtowicz A, Gresnigt MS, Lecompte T, Bibert S, Manuel O, Joosten LA, Rüeger S, Berger C, Boggian K, Cusini A, Garzoni C, Hirsch HH, Weisser M, Mueller NJ, Meylan PR, Steiger J, Kutalik Z, Pascual M, van Delden C, van de Veerdonk FL, Bochud PY; Swiss Transplant Cohort Study (STCS); Swiss Transplant Cohort Study. IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.
    J Infect Dis. 2015; 211:1646-57. [IF: 5.8, R: 43/72]
  40. Manuel O, Wójtowicz A, Bibert S, Mueller NJ, van Delden C, Hirsch HH, Steiger J, Stern M, Egli A, Garzoni C, Binet I, Weisser M, Berger C, Cusini A, Meylan P, Pascual M, Bochud PY; Swiss Transplant Cohort Study (STCS); Swiss Transplant Cohort Study. Influence of IFNL3/4 Polymorphisms on the Incidence of Cytomegalovirus Infection After Solid-Organ Transplantation.
    J Infect Dis. 2015; 211 906-14. [IF: 5.8, R: 43/72]
  41. Koenig KF, Ribi C, Radosavac M, Zulewski H, Trendelenburg M; Swiss SLE cohort study (SSCS). Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts.
    Lupus 2015; 24: 58-65. [IF: 2.5, R: 18/30]
  42. Schiesser M, Steinemann DC, Hadaya K, Huynh-Do U, Eisenberger U, Binet I, Fehr T, Dickenmann M. The reuse of immunoadsorption columns in ABO incompatible kidney transplantation is safe and efficient: Report of the Swiss multi-center ABO incompatible kidney transplantation experience
    Transplantation 2015; 99:1030-5 [IF: 3.8, R: 4/25]
  43. Zimmer J, Dahldal S, Mühlfeld C, Bergmann I, Gugger M, Huynh-Do U. Lymphangiogenesis is upregulated in kidneys of multiple myeloma patients.
    Anat Record 2010; 293: 1497-1505 [IF: 1.7, R: 8/17]
  44. Cybulla M et al, on behalf of the Fabry Outcome Survey investigators. Kidney transplantation in patients with Fabry disease.
    Transpl Int 2009; 22:475-81 [IF:3.1,R:11/26]
  45. Mehta A et al, on behalf of the Fabry Outcome Survey investigators. Enzyme replacement therapy with agalsidase alfa in patients with Fabry’s disease: an analysis of registry data.
    Lancet 2009; 374: 1986 – 1996. [IF: 28.4, R: 3/107]
  46. Uehlinger DE, Jakob SM, Ferrari P, Eichelberger M, Huynh-Do U, Marti HP, Mohaupt MG, Vogt B, Rothen HU, Regli B, Takala J, Frey FJ. A comparison of continuous and intermittent renal replacement therapy for acute renal failure.
    Neph Dial Transpl. 2005; 8: 1630-7 [IF: 2.9, R: 9/52]
  47. Vogt B, Ferrari P, Schönholzer C, Marti HP, Mohaupt M, Wiederkehr M, Cereghetti C, Serra A, Huynh-Do U, Uehlinger D, Frey FJ.. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful.
    Am J Med. 2001; 111:692-698 [IF: 6.1, R: 8/112]
  48. Grünenfelder J, von Segesser LK, Huynh-Do U, Binswanger U, Turina MI. Is hemofiltration after acute kidney failure in elderly cardiovascular surgery patients justified?
    Swiss Med Weekly 1997; 127:53-59 [IF: 0.4, R: 63/98]
  49. Gantenbein H, Bachmann P, Huynh U, Steinhauslin F, Weinreich T, Schlumpf R, Largiader F, Binswanger U. Comparison of two antilymphocyte globulins replacing Cyclosporin A after first kidney allotransplantation and prolonged graft ischemia.
    Clin Transplantation 1996; 10:384-385 [IF: 1.7, R:22/107]
  50. Huynh-Do U, Binswanger U. Practical experience with CAPD quantification: relationship to clinical outcome and adaptation of therapy.
    Perit Dial Int 1995; 15:165-167 [IF: 1.8, R: 12/36]
  51. Bansky G, Huynh-Do U, Largiadèr F, Binswanger U. Gastroduodenal complications after renal transplantation: The role of prophylactic gastric surgery in hyperacid kidney allograft recipients.
    Clin Transplantation 1987; 1:209-213 [IF: 1.6, R: 41/141]

Peer-reviewed publications in basic sciences

  1. Claus M, Herro R, Wolf D, Buscher K, Rudloff S, Huynh-Do U, Burkly L, Croft M, Sidler D. The TWEAK/Fn14 pathway is critically involved in Calcineurin Inhibitor Toxicity of the Kidneys.
    Am J Tpl 2017 Dec 21. doi: 10.1111/ajt.14632. [IF: 5.7, R: 2/25]
  2. Hlushchuk R, Styp-Rekowska B, Dzambazi J, Wnuk M, Huynh-Do U, Makanya A, Djonov. V.Endoglin inhibition leads to intussusceptive angiogenesis via activation of factors related to COUP-TFII signaling pathway.
    Plos One 2017; 12(8):e0182813. doi: 10.1371/journal.pone.0182813 [[IF: 3.3, R: 8/56]
  3. Pflug T, Huynh-Do U, Rudloff S. Low canonical Wnt signaling affects bone primordium organization, but not bone formation.
    Biol Open 2017; 6:582-588. [IF 2.1, R: 3/63]
  4. Rodriguez S, Rudloff S, Koenig KF, Karthik S, Hoogewijs D, Huynh-Do U. EphA2/ephrinA1 bidirectional signalling increases tubular cell attachment, laminin secretion and erythropoietin expression after renal hypoxic injury.
    Pflugers Arch – Eur J Physiol Pflugers 2016; 468:1433-48 [IF 4.1, R: 13/83]
  5. Janot M, Cortes-Dubly ML, Rodriguez S, Huynh-Do U. Bilateral uterine artery ligation as a model of intrauterine growth restriction in mice.
    Reprod Biol Endocrinol 2014, 12:62; DOI: 10.1186/1477-7827-12-62 [IF 2.2, R: 17/28]
  6. Frese-Schaper M, Keil A, Steiner SK, Gugger M, Körner M, Kocher GJ, Schiffer L, Anders HJ, Huynh-Do U, Schmid RA, Frese S. Low doses irinotecan improves advanced lupus nephritis in mice potentially by changing DNA relaxation and anti-dsDNA binding.
    Arthr Rheum 2014; 66: 2259-69. [IF 7.5, R: 3/29]
  7. Boissier P, Chen J, Huynh-Do U. EphA2 signalling following endocytosis: Role of Tiam-1.
    Traffic 2013, 14: 1255-71, doi: 10.1111/tra.12123 [IF: 4.9, R: 53/184]
  8. Eckey C, Gugger M, U. Huynh-Do. EphA2 protein expression in metastatic renal cell carcinoma treated with VEGF-inhibitors may be associated with patient survival.
    J Solid Tumors 2013; 3: 12-21
  9. Rodriguez S and Huynh-Do U. PTEN regulates stability and activity of EphB1 receptor.
    FASEB J. 2013, 27: 632-644, doi: 10.1096/fj.12-215582 [IF: 5.7, R: 7/84]
  10. Wnuk M, Hlushchuk R, Janot M, Tuffin G, Martiny-Baron G, Holzer P, Imbach-Weese P, Djonov V, Huynh-Do U. Podocyte EphB4 signaling helps recovery from glomerular injury.
    Kidney International 2012; 81: 1212-1255* [IF: 6.1, R: 3:69] * Cover page and editorial of the journal issue
  11. Wnuk M, Hlushchuk R, Tuffin G, Huynh-Do U*, Djonov V*. The effects of PTK787/ ZK222584, an inhibitor of VEGFR and PDGFRβ pathways, on intussusceptive angiogenesis and glomerular recovery from Thy1.1 nephritis * both authors contributed equally to the manuscript
    Am J Pathol 2011; 178: 1899-1912 [IF: 5.7, R: 2/69]
  12. Ingueneau C, Huynh-Do U, Thiers JC, Nègre-Salvayre A, Salvayre R, Vindis C TRPC1 is regulated by caveolin-1 and is involved in oxidized LDL-induced apoptosis of vascular smooth muscle cells.
    J Cell Mol Med 2009; 13: 1620-1631 [IF: 6.8, R: 30/263]
  13. Fasen F, Cerretti DP, Huynh-Do U. Ligand binding induces c-Cbl dependent EphB1 receptor degradation.
    Traffic 2008; 9:251-266 [IF: 6.7, R: 28/156]
  14. Ingueneau C, Huynh-Do U, Thiers JC, Nègre-Salvayre A, Salvayre R, Vindis C. Caveolin-1 sensitizes vascular smooth muscle cells to mildly oxidized LDL-induced apoptosis.
    BBRC 2008; 369:889-93 [IF: 2.9, R: 109/202]
  15. Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FH, Farese S. Sodium-thiosulfate treatment prevents vascular calcification in uremic rats.
    Kidney International 2008, 74: 1444-1453 [IF: 4.9, R: 4/55]
  16. Vihanto MM, Vindis C, Djonov V, Cerretti DP, Huynh-Do U. Caveolin-1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinase.
    J Cell Science 2006; 119: 2299-2309 [IF: 6.9, R:23/155]
  17. Casal AJ, Sinclair VJ, Capponi AM, Nicod J, Huynh-Do U, Ferrari P. A novel mutation in the steroidogenic acute regulatory (StAR) protein gene promoter leading to reduced promoter activity.
    J Mol Endocrinol 2006; 37: 71-80 [IF: 3.9, R: 19/87]
  18. Vihanto MM, Vindis C, Djonov V, Cerretti DP, Huynh-Do U. Hypoxia upregulates expression of Eph receptors and ephrins in mouse skin.
    FASEB J. 2005; 19: 1689-91, doi: 10.1096/fj.04-3647fje [IF: 7.2, R: 1/65]
  19. Vindis C, Teli T, Cerretti DP, Turner CE, Huynh-Do U. EphB1-mediated cell migration requires the phosphorylation of paxillin at Y31 and Y118.
    J Biol Chem 2004; 279: 27965-27970 [IF: 6.4, R: 31/261]
  20. Vindis C, Cerretti DP, Daniel TO, Huynh-Do U. EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis.
    J Cell Biol 2003; 162: 661-671 [IF: 12, R: 11/156]
  21. Huynh-Do U, Vindis C, Liu H, Cerretti DP, McGrew JT, Enriquez M, Chen J, Daniel TO. EphrinB1 transduces signals to activate integrin-mediated migration attachment and angiogenesis.
    J Cell Science 2002; 115: 3073-3081 [IF: 7.0, R: 23/153]
  22. Becker E, Huynh-Do U, Holland S, Pawson T, Daniel TO, Skolnik EY.. Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation.
    Mol Cell Biol 2000; 20:1537-1545 [IF: 9.9, R: 8/107]
  23. Huynh-Do U, Stein E, Lane AA, Liu H, Cerretti DP, Daniel TO. Surface densities of EphrinB1 determine EphB1-coupled activation of cell attachment through α5β1 and αVβ3 integrins.
    EMBO Journal 1999; 18: 2165-2173 [IF: 14.0, R: 5/107]
  24. Stein E, Huynh-Do U, Lane AA, Cerretti DP, Daniel TO. Adapter protein, Nck, binds ligand-activated Eph1 receptors coincident with activation of JUN/SAP kinase.
    J Biol Chem 1998; 273:1303-1308 [IF: 7.7, R: 21/227]
  25. Huynh-Do U, Neftel K, Spadari S, Hübscher U. Betalactam antibiotics interfere with eukaryotic DNA replication by inhibiting DNA-polymerase α.
    Nucl Acids Res 1987; 15:10495-10506 [IF: 7.1, R: 25/266]
  26. Hübscher U, Huynh-Do U, Hässig M, Neftel K. Effects of Betalactams on DNA replication.
    Cell Biol Toxicol 1986; 2:541-548 [IF:1.3, R:110/153]